α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?

Abstract

Available α1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the α1A adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.

• Authors: Claus G Roehrborn, Francisco Cruz, Ferdinando Fusco
• Journal: Advances in therapy (Adv Ther) Vol. 33 Issue 12 Pg. 2110-2121 (01 2017) ISSN: 1865-8652 [Electronic] United States
• PMID: 27752927 (Publication Type: Journal Article, Review)

Chemical References

• Adrenergic alpha-1 Receptor Antagonists

Topics

• Adrenergic alpha-1 Receptor Antagonists (pharmacology, therapeutic use)
• Adult
• Aged
• Aged, 80 and over
• Humans
• Lower Urinary Tract Symptoms (drug therapy)
• Male
• Middle Aged
• Nocturia (drug therapy)
• Prostatic Hyperplasia (drug therapy)
• Urinary Bladder Neck Obstruction (drug therapy)